Filing Details
KIORA PHARMACEUTICALS INC (NASDAQ:KPRX) filed a Form 8-K with the Securities and Exchange Commission on August 19, 2026, disclosing a material event.
8k filedNASDAQ:KPRX
KIORA PHARMACEUTICALS INC (KPRX) Reports Material Event to SEC
KIORA PHARMACEUTICALS INC (NASDAQ:KPRX) filed a Form 8-K with the Securities and Exchange Commission on August 19, 2026, disclosing a material event.
At publication ·
What changed
KIORA PHARMACEUTICALS INC (NASDAQ:KPRX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- KIORA PHARMACEUTICALS INC (NASDAQ: KPRX) filed a Form 8-K with the SEC on August 19, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $2.60 with a market capitalization of $7.9 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
KIORA PHARMACEUTICALS INC's stock currently trades at $2.60 with a market capitalization of $7.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for KIORA PHARMACEUTICALS INC's stock.
All SEC filings for KIORA PHARMACEUTICALS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View KPRX Stock Page
Frequently Asked Questions
Where can I read KPRX's SEC filings?
Browse all filings on our KPRX SEC filings page.
What types of SEC filings does KIORA PHARMACEUTICALS INC file?
Public companies like KIORA PHARMACEUTICALS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.